Natalie Duerkopp1 article listing Natalie Duerkopp in Nature Communications, indexed by Paperzzz from Crossref and OSF.A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence Nature Communications